227 related articles for article (PubMed ID: 22973031)
1. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.
Yoder JD; Cifuente JO; Pan J; Bergelson JM; Hafenstein S
J Virol; 2012 Dec; 86(23):12571-81. PubMed ID: 22973031
[TBL] [Abstract][Full Text] [Related]
2. Interaction of decay-accelerating factor with coxsackievirus B3.
Hafenstein S; Bowman VD; Chipman PR; Bator Kelly CM; Lin F; Medof ME; Rossmann MG
J Virol; 2007 Dec; 81(23):12927-35. PubMed ID: 17804498
[TBL] [Abstract][Full Text] [Related]
3. Interaction of decay-accelerating factor with echovirus 7.
Plevka P; Hafenstein S; Harris KG; Cifuente JO; Zhang Y; Bowman VD; Chipman PR; Bator CM; Lin F; Medof ME; Rossmann MG
J Virol; 2010 Dec; 84(24):12665-74. PubMed ID: 20881044
[TBL] [Abstract][Full Text] [Related]
4. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
Shafren DR; Williams DT; Barry RD
J Virol; 1997 Dec; 71(12):9844-8. PubMed ID: 9371658
[TBL] [Abstract][Full Text] [Related]
5. Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.
Pan J; Zhang L; Organtini LJ; Hafenstein S; Bergelson JM
J Virol; 2015 Jan; 89(2):1324-8. PubMed ID: 25392210
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of differential receptor usage for naturally occurring CD55-binding and -nonbinding coxsackievirus B3 strains.
Wang Q; Yang Q; Liu C; Wang G; Song H; Shang G; Peng R; Qu X; Liu S; Cui Y; Wang P; Xu W; Zhao X; Qi J; Yang M; Gao GF
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35046043
[TBL] [Abstract][Full Text] [Related]
7. Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.
Carson SD; Chapman NM; Hafenstein S; Tracy S
J Virol; 2011 Apr; 85(7):3306-14. PubMed ID: 21270163
[TBL] [Abstract][Full Text] [Related]
8. Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.
He Y; Lin F; Chipman PR; Bator CM; Baker TS; Shoham M; Kuhn RJ; Medof ME; Rossmann MG
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10325-9. PubMed ID: 12119400
[TBL] [Abstract][Full Text] [Related]
9. Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor.
Pan J; Narayanan B; Shah S; Yoder JD; Cifuente JO; Hafenstein S; Bergelson JM
J Virol; 2011 Jul; 85(14):7436-43. PubMed ID: 21561916
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional insights into the interaction of echoviruses and decay-accelerating factor.
Pettigrew DM; Williams DT; Kerrigan D; Evans DJ; Lea SM; Bhella D
J Biol Chem; 2006 Feb; 281(8):5169-77. PubMed ID: 16272562
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
[TBL] [Abstract][Full Text] [Related]
12. The structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decay-accelerating factor (CD 55).
Bhella D; Goodfellow IG; Roversi P; Pettigrew D; Chaudhry Y; Evans DJ; Lea SM
J Biol Chem; 2004 Feb; 279(9):8325-32. PubMed ID: 14634014
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).
Bergelson JM; Mohanty JG; Crowell RL; St John NF; Lublin DM; Finberg RW
J Virol; 1995 Mar; 69(3):1903-6. PubMed ID: 7531780
[TBL] [Abstract][Full Text] [Related]
14. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
[TBL] [Abstract][Full Text] [Related]
15. Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells.
Patel KP; Coyne CB; Bergelson JM
J Virol; 2009 Nov; 83(21):11064-77. PubMed ID: 19710132
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3.
Pasch A; Küpper JH; Wolde A; Kandolf R; Selinka HC
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3153-3158. PubMed ID: 10567646
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
[TBL] [Abstract][Full Text] [Related]
18. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and structural analysis of coxsackievirus B3 receptor interactions and formation of the A-particle.
Organtini LJ; Makhov AM; Conway JF; Hafenstein S; Carson SD
J Virol; 2014 May; 88(10):5755-65. PubMed ID: 24623425
[TBL] [Abstract][Full Text] [Related]
20. Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.
Karnauchow TM; Dawe S; Lublin DM; Dimock K
J Virol; 1998 Nov; 72(11):9380-3. PubMed ID: 9765493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
